WallStreetZenWallStreetZen

NASDAQ: APLS
Apellis Pharmaceuticals Inc Stock Ownership - Who owns Apellis Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Apellis Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David O. WatsonGeneral Counsel2025-11-175,000$20.06
$100.30kSell
Timothy Eugene SullivanChief Financial Officer2025-10-2110,000$28.03
$280.30kSell
Timothy Eugene SullivanChief Financial Officer2025-10-2110,000$10.03
$100.30kBuy
David O. WatsonGeneral Counsel2025-10-165,000$25.22
$126.10kSell
A. Sinclair DunlopDirector2025-10-1031,092$23.72
$737.53kSell
A. Sinclair DunlopDirector2025-09-3031,092$22.58
$702.06kSell
A. Sinclair DunlopDirector2025-09-1931,092$22.95
$713.56kSell
David O. WatsonGeneral Counsel2025-09-165,000$24.34
$121.70kSell
James George ChopasVPChief Accounting Officer2025-09-15189$24.19
$4.57kSell
David O. WatsonGeneral Counsel2025-09-1020,000$26.17
$523.40kSell

1 of 8

APLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when APLS insiders and whales buy or sell their stock.

APLS Shareholders

What type of owners hold Apellis Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morningside Venture Investments Ltd10.12%12,806,342$316.06MInsider
Avoro Capital Advisors LLC9.66%12,222,222$301.64MInstitution
Vanguard Group Inc7.89%9,987,394$246.49MInstitution
Morgan Stanley7.62%9,643,248$238.00MInstitution
Wellington Management Group LLP7.34%9,290,960$229.30MInstitution
Deep Track Capital LP6.32%8,000,382$197.45MInstitution
Blackrock Inc4.95%6,268,465$154.71MInstitution
Aqr Capital Management LLC3.55%4,487,354$110.75MInstitution
Jennison Associates LLC3.44%4,348,055$107.31MInstitution
State Street Corp3.19%4,037,644$99.65MInstitution

1 of 3

APLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
APLS76.30%23.70%Net SellingNet Selling
TLX0.25%0.00%
TVTX63.49%36.51%Net SellingNet Selling
OCUL83.72%16.28%Net SellingNet Selling
VRDN74.98%25.02%Net BuyingNet Buying
View Top Biotech Stocks

Apellis Pharmaceuticals Stock Ownership FAQ

Who owns Apellis Pharmaceuticals?

Apellis Pharmaceuticals (NASDAQ: APLS) is owned by 96.70% institutional shareholders, 30.04% Apellis Pharmaceuticals insiders, and 0.00% retail investors. Morningside Venture Investments Ltd is the largest individual Apellis Pharmaceuticals shareholder, owning 12.81M shares representing 10.12% of the company. Morningside Venture Investments Ltd's Apellis Pharmaceuticals shares are currently valued at $319.71M.

If you're new to stock investing, here's how to buy Apellis Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.